Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10010)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2014 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tarocchi M, Polvani S, Marroncini G, Galli A. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol 2014; 20(33): 11630-11640 [PMID: 25206269 DOI: 10.3748/wjg.v20.i33.11630] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i33/11630.htm |
| Number | Citing Articles |
| 1 |
Chiao-Fang Teng, Tsai-Chung Li, Hsi-Yuan Huang, Jia-Hui Lin, Wen-Shu Chen, Woei-Cherng Shyu, Han-Chieh Wu, Cheng-Yuan Peng, Ih-Jen Su, Long-Bin Jeng. Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence. Viruses 2020; 12(8): 796 doi: 10.3390/v12080796
|
| 2 |
Yan Ma, Xiaoqian Wang, Nanhong Tang. Downregulation of mPGES-1 ExpressionviaEGR1 Plays an Important Role in Inhibition of Caffeine on PGE2Synthesis of HBx(+) Hepatocytes. Mediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/372750
|
| 3 |
Olorunseun O Ogunwobi, Trisheena Harricharran, Jeannette Huaman, Anna Galuza, Oluwatoyin Odumuwagun, Yin Tan, Grace X Ma, Minhhuyen T Nguyen. Mechanisms of hepatocellular carcinoma progression. World Journal of Gastroenterology 2019; 25(19): 2279-2293 doi: 10.3748/wjg.v25.i19.2279
|
| 4 |
Tomasz I. Michalak. The Initial Hepatitis B Virus-Hepatocyte Genomic Integrations and Their Role in Hepatocellular Oncogenesis. International Journal of Molecular Sciences 2023; 24(19): 14849 doi: 10.3390/ijms241914849
|
| 5 |
Dong‐Hwan Jung, Shin Hwang, Ki‐Hun Kim, Seung‐Mo Hong, Young‐Joo Lee, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Gil‐Chun Park, Eun Sil Yu, Sung‐Gyu Lee. Clinicopathological Features and Post‐resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. World Journal of Surgery 2017; 41(3): 825 doi: 10.1007/s00268-016-3787-4
|
| 6 |
Jianbo Xianyu, Jiafu Feng, Yuwei Yang, Jie Tang, Gang Xie, Lingying Fan. Correlation of oxidative stress in patients with HBV-induced liver disease with HBV genotypes and drug resistance mutations. Clinical Biochemistry 2018; 55: 21 doi: 10.1016/j.clinbiochem.2018.03.014
|
| 7 |
Rolando Herrero, Loretto J. Carvajal, M. Constanza Camargo, Arnoldo Riquelme, Carolina Porras, Ana Patricia Ortiz, Luis Aranha Camargo, Valeria Fink, Vanessa van De Wyngard, Eduardo Lazcano-Ponce, Carlos Canelo-Aybar, Graciela Balbin-Ramon, Ariadna Feliu, Carolina Espina. Latin American and the Caribbean Code Against Cancer 1st edition: Infections and cancer. Cancer Epidemiology 2023; 86: 102435 doi: 10.1016/j.canep.2023.102435
|
| 8 |
Jian Han, Thomas Thurnherr, Alexander Y. F. Chung, Brian K. P. Goh, Pierce K. H. Chow, Chung Yip Chan, Peng Chung Cheow, Ser Yee Lee, Tony K. H. Lim, Samuel S. Chong, London L. P. J. Ooi, Caroline G. Lee. Clinicopathological-Associated Regulatory Network of Deregulated circRNAs in Hepatocellular Carcinoma. Cancers 2021; 13(11): 2772 doi: 10.3390/cancers13112772
|
| 9 |
Rachel Hiu Ha Ching, Karen Man Fong Sze, Eunice Yuen Ting Lau, Yung-Tuen Chiu, Joyce Man Fong Lee, Irene Oi Lin Ng, Terence Kin Wah Lee. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway. Oncotarget 2017; 8(14): 23507 doi: 10.18632/oncotarget.15183
|
| 10 |
Kuo‑Shyang Jeng, Chi‑Juei Jeng, Wen‑Juei Jeng, I‑Shyan Sheen, Shih‑Yun Li, Chuen‑Miin Leu, Yeou‑Guang Tsay, Chiung‑Fang Chang. Sonic Hedgehog signaling pathway as a potential target to inhibit the progression of hepatocellular carcinoma (Review). Oncology Letters 2019; doi: 10.3892/ol.2019.10826
|
| 11 |
Yesol Bak, Hye-jun Shin, In seon Bak, Do-young Yoon, Dae-Yeul Yu. Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway. Biochemical and Biophysical Research Communications 2015; 466(4): 676 doi: 10.1016/j.bbrc.2015.09.082
|
| 12 |
Isabel R. Fulcher, Ilya Shpitser, Vanessa Didelez, Kali Zhou, Daniel O. Scharfstein. Discussion on “Causal mediation of semicompeting risks” by Yen‐Tsung Huang. Biometrics 2021; 77(4): 1165 doi: 10.1111/biom.13519
|
| 13 |
Y. V. Panasiuk, N. V. Vlasenko, N. S. Churilova, V. V. Klushkina, D. V. Dubodelov, E. N. Kudryavtseva, M. I. Korabelnikova, Z. S. Rodionova, T. A. Semenenko, S. N. Kuzin, V. G. Akimkin. Modern views on the role of <i>X</i> gene of the hepatitis B virus (<i>Hepadnaviridae: Orthohepadnavirus: Hepatitis B virus</i>) in the pathogenesis of the infection it causes. Problems of Virology 2022; 67(1): 7 doi: 10.36233/0507-4088-84
|
| 14 |
Federico Costante, Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Tarik Asselah, Francesca Romana Ponziani. Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection. Journal of Hepatocellular Carcinoma 2023; : 713 doi: 10.2147/JHC.S384751
|
| 15 |
Sharon Kuss-Duerkop, Joseph Westrich, Dohun Pyeon. DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis. Viruses 2018; 10(2): 82 doi: 10.3390/v10020082
|
| 16 |
Abigail Morales-Sánchez, Ezequiel Fuentes-Pananá. Human Viruses and Cancer. Viruses 2014; 6(10): 4047 doi: 10.3390/v6104047
|
| 17 |
Maria Bousali, George Papatheodoridis, Dimitrios Paraskevis, Timokratis Karamitros. Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma. Microorganisms 2021; 9(8): 1787 doi: 10.3390/microorganisms9081787
|
| 18 |
Baxter Hepburn Kachingwe, Li‐Hsuan Wang, Yow‐Shieng Uang, Tsurng‐Juhn Huang, Shwu‐Jiuan Lin. Dose‐dependent pharmacokinetics and tentative identification of urine metabolites from an isosteviol derivative with anti‐hepatitis B activity in rats. Biomedical Chromatography 2018; 32(9) doi: 10.1002/bmc.4266
|
| 19 |
Jin Ho Shin, Chong Jai Kim, Eun Jeong Jeon, Chang Ohk Sung, Hwa Jeong Shin, Jene Choi, Eunsil Yu. Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas. Journal of Pathology and Translational Medicine 2015; 49(2): 105 doi: 10.4132/jptm.2015.01.19
|
| 20 |
Yu Zhang, Hongli Liu, Ruitian Yi, Taotao Yan, Yingli He, Yingren Zhao, Jinfeng Liu. Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0366-3
|
| 21 |
|
| 22 |
Chengliang Zhu, Hengcheng Zhu, Hui Song, Limin Xu, Longxuan Li, Fang Liu, Xinghui Liu. Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3. Lipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0607-2
|
| 23 |
Sergey Brezgin, Anastasiia Kostyusheva, Ekaterina Bayurova, Ilya Gordeychuk, Maria Isaguliants, Irina Goptar, Anastasiia Nikiforova, Valery Smirnov, Elena Volchkova, Dieter Glebe, Dmitry Kostyushev, Vladimir Chulanov. Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro. Microorganisms 2019; 7(11): 533 doi: 10.3390/microorganisms7110533
|
| 24 |
Hao Zhang, Xuebing Chen, Jian Zhang, Xianwei Wang, Huijuan Chen, Lin Liu, Shanling Liu. Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review). International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4909
|
| 25 |
Bulent Baran. Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma. World Journal of Hepatology 2015; 7(13): 1742-1754 doi: 10.4254/wjh.v7.i13.1742
|
| 26 |
Sumira Malik, Shilpa Prasad, Shristi Kishore, Abhishek Kumar, Vineet Upadhyay. A perspective review on impact and molecular mechanism of environmental carcinogens on human health. Biotechnology and Genetic Engineering Reviews 2021; 37(2): 178 doi: 10.1080/02648725.2021.1991715
|
| 27 |
Sara Naimimohasses, Omar El Sherif, Mohammad Ashfaq, Niamh Nolan, Masood Iqbal, Susan McKiernan, Suzanne Norris. Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma. Case Reports in Gastroenterology 2017; 11(3): 797 doi: 10.1159/000484660
|
| 28 |
Yunhua Wu, Fenggang Ren, Yichao Chai, Zhao Xue, Cong Shen, Xufeng Zhang, Yi Lv, Liangshuo Hu. Prognostic value of inflammation‑based indexes for intrahepatic cholangiocarcinoma following curative resection. Oncology Letters 2018; doi: 10.3892/ol.2018.9618
|
| 29 |
Krishnapriya Ramakrishnan, Sreeranjini Babu, Vineetha Shaji, Sowmya Soman, Anila Leelamma, Niyas Rehman, Rajesh Raju. Hepatitis B Virus Modulated Transcriptional Regulatory Map of Hepatic Cellular MicroRNAs. OMICS: A Journal of Integrative Biology 2023; 27(12): 581 doi: 10.1089/omi.2023.0171
|
| 30 |
Yanan Pang, Weixing Guo, Jiaqi Wang, Guixia Xu, Kai Cheng, Guangwen Cao, Mengchao Wu, Shuqun Cheng, Shanrong Liu. Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA. Oncotarget 2016; 7(7): 8006 doi: 10.18632/oncotarget.6895
|
| 31 |
Shringar Rao, Tanvir Hossain, Tokameh Mahmoudi. 3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis. Cancer Letters 2021; 506: 35 doi: 10.1016/j.canlet.2021.02.024
|
| 32 |
Rongqiang Liu, Shiyang Zheng, Qing Yuan, Peiwen Zhu, Biao Li, Qi Lin, Wenqing Shi, Youlan Min, Qianmin Ge, Yi Shao, Giorgio Ghigliotti. The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/4565379
|
| 33 |
Lindsay M. Wong, Wei Tse Li, Neil Shende, Joseph C. Tsai, Jiayan Ma, Jaideep Chakladar, Aditi Gnanasekar, Yuanhao Qu, Kypros Dereschuk, Jessica Wang-Rodriguez, Weg M. Ongkeko. Analysis of the immune landscape in virus-induced cancers using a novel integrative mechanism discovery approach. Computational and Structural Biotechnology Journal 2021; 19: 6240 doi: 10.1016/j.csbj.2021.11.013
|
| 34 |
Mariana Nassif Kerbauy, Carolina Melo Fernandes, Evandro Dantas Bezerra, Luis Alberto de Padua Covas Lage, Sheila Aparecida Coelho Siqueira, Juliana Pereira. Splenic diffuse red-pulp small B-cell lymphoma associated with hepatitis B virus: a report of two cases. Sao Paulo Medical Journal 2016; 134(4): 359 doi: 10.1590/1516-3180.2016.0035130416
|
| 35 |
Yongzhen Liu, Xuewei Qi, Zhenzhen Zeng, Lu Wang, Jie Wang, Ting Zhang, Qiang Xu, Congle Shen, Guangde Zhou, Shaomin Yang, Xiangmei Chen, Fengmin Lu. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03070-8
|
| 36 |
Chandrabose Selvaraj, Gurunathan Rubha Shri, Rajendran Vijayakumar, Abdulaziz S. Alothaim, Saravanan Ramya, Sanjeev Kumar Singh. Protein Interaction Networks. Advances in Protein Chemistry and Structural Biology 2022; 131: 261 doi: 10.1016/bs.apcsb.2022.05.001
|
| 37 |
Caroline Lefeuvre, Hélène Le Guillou-Guillemette, Alexandra Ducancelle. A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis. International Journal of Molecular Sciences 2021; 22(24): 13651 doi: 10.3390/ijms222413651
|
| 38 |
R. N. Mustafin. Hypothesis on the Origin of Viruses from Transposons. Molecular Genetics, Microbiology and Virology 2018; 33(4): 223 doi: 10.3103/S0891416818040067
|
| 39 |
Samane Shakibaie, Hoomaan Joze-Majidi, Erfan Zabihi, Mahboobeh Ramezani, Saeedeh Ebrahimi, Zahra Arab-Bafrani, Elham Mousavi. Development and Characterization of Graphene Oxide-Locust Bean Gum-Zinc Oxide (GO-LBG-ZnO) Nanohybrid as an Efficient and Novel Antitumor Agent against Hepatocarcinoma Cells. Journal of Polymers and the Environment 2024; doi: 10.1007/s10924-023-03184-3
|
| 40 |
Pu-Yang Gong, Zhi-Xiang Yuan, Jian Gu, Rui Tan, Jia-Chuan Li, Yan Ren, Sha Hu. Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds. Molecules 2016; 22(1): 14 doi: 10.3390/molecules22010014
|
| 41 |
Sayed Shahabuddin Hoseini, Nai-Kong V. Cheung. Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies. Cancer Letters 2017; 399: 44 doi: 10.1016/j.canlet.2017.04.013
|
| 42 |
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco. The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis. Cancers 2024; 16(8): 1505 doi: 10.3390/cancers16081505
|
| 43 |
Janos Minarovits, Anett Demcsák, Ferenc Banati, Hans Helmut Niller. Patho-Epigenetics of Infectious Disease. Advances in Experimental Medicine and Biology 2016; 879: 71 doi: 10.1007/978-3-319-24738-0_4
|
| 44 |
Anabel Fernández-Iglesias, Diana Hide, Jordi Gracia-Sancho. Gastrointestinal Tissue. 2017; : 125 doi: 10.1016/B978-0-12-805377-5.00009-6
|
| 45 |
Jafar Ai, Neda Ketabchi, Javad Verdi, Nematollah Gheibi, Hossein Khadem Haghighian, Maria Kavianpour. Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1038-0
|
| 46 |
Chanchan Xiao, Fanbiao Mei, Guanhua Ren, Long Long, Maojian Chen, Xiang Fang, Jilin Li, Kezhi Li, Yanping Tang, Tianren Huang, Wei Deng. Synergistic Effect of MC-LR and C-Terminal Truncated HBx on HepG2 Cells and Their Effects on PP2A Mediated Downstream Target of MAPK Signaling Pathway. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.537785
|
| 47 |
Yingqiang Zhang, Guihua Huang, Hongfei Miao, Ze Song, Xiaoying Zhang, Wenzhe Fan, Yu Wang, Jiaping Li, Yong Chen. Apatinib treatment may improve survival outcomes of patients with hepatitis B virus-related sorafenib-resistant hepatocellular carcinoma. Therapeutic Advances in Medical Oncology 2020; 12: 175883592093742 doi: 10.1177/1758835920937422
|
| 48 |
Yali Wu, Xiaolei Zhang, Yongzhen Liu, Fengmin Lu, Xiangmei Chen. Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2016; 17(2): 153 doi: 10.3390/ijms17020153
|
| 49 |
Amy P Chiu, Barbara R Tschida, Lilian H Lo, Branden S Moriarity, Dewi K Rowlands, David A Largaespada, Vincent W Keng. Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12157-12170 doi: 10.3748/wjg.v21.i42.12157
|
| 50 |
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, Sara Battistella, Barbara Penzo, Patrizia Burra, Fabio Farinati. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?. International Journal of Molecular Sciences 2022; 23(1): 500 doi: 10.3390/ijms23010500
|
| 51 |
|
| 52 |
Shabnam Shalapour, Michael Karin. Cruel to Be Kind: Epithelial, Microbial, and Immune Cell Interactions in Gastrointestinal Cancers. Annual Review of Immunology 2020; 38(1): 649 doi: 10.1146/annurev-immunol-082019-081656
|
| 53 |
Sarah Hyun, Okhyun Ko, Soonsik Kim, William R. Ventura. Sociocultural barriers to hepatitis B health literacy in an immigrant population: a focus group study in Korean Americans. BMC Public Health 2021; 21(1) doi: 10.1186/s12889-021-10441-4
|
| 54 |
Xiaobo Lin, Weiping Chang, Yuan Wang, Ming Tian, Zhaoxiang Yu. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017; 93: 398 doi: 10.1016/j.biopha.2017.06.075
|
| 55 |
H Y Yamada, G Kumar, Y Zhang, E Rubin, S Lightfoot, W Dai, C V Rao. Systemic chromosome instability in Shugoshin-1 mice resulted in compromised glutathione pathway, activation of Wnt signaling and defects in immune system in the lung. Oncogenesis 2016; 5(8): e256 doi: 10.1038/oncsis.2016.56
|
| 56 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
| 57 |
Chiao-Fang Teng, Han-Chieh Wu, Ih-Jen Su, Long-Bin Jeng. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma. Viruses 2020; 12(9): 945 doi: 10.3390/v12090945
|
| 58 |
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World Journal of Gastroenterology 2022; 28(21): 2251-2281 doi: 10.3748/wjg.v28.i21.2251
|
| 59 |
Jiawei Rao, Xukun Wu, Xiaozhuan Zhou, Ronghai Deng, Yi Ma. Vitamin D Receptor Fok I Polymorphism and Risk of Hepatocellular Carcinoma in HBV-Infected Patients. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.85075
|
| 60 |
Usama W. Hawas, Mohamed A. El-Ansari, Abeer F. Osman, Asmaa F. Galal, Lamia T. Abou El-Kassem. Flavonoid constituents and protective efficacy of Citrus reticulate (Blanco) leaves ethanolic extract on thioacetamide-induced liver injury rats. Biomarkers 2023; 28(2): 160 doi: 10.1080/1354750X.2022.2151645
|
| 61 |
Fei Tang, Guanghua Huang, Liping Lin, Hong Yin, Lili Shao, Ruian Xu, Xiuling Cui. Anti-HBV Activities of Polysaccharides from Thais clavigera (Küster) by In Vitro and In Vivo Study. Marine Drugs 2021; 19(4): 195 doi: 10.3390/md19040195
|
| 62 |
Saadyeh Rashidi, Leila Farhadi, Faezeh Ghasemi, Farshad Sheikhesmaeili, Asadollah Mohammadi. The potential role of HLA-G in the pathogenesis of HBV infection: Immunosuppressive or immunoprotective?. Infection, Genetics and Evolution 2020; 85: 104580 doi: 10.1016/j.meegid.2020.104580
|
| 63 |
Yingqiang Zhang, Wenzhe Fan, Kangshun Zhu, Ligong Lu, Sirui Fu, Jinhua Huang, Yu Wang, Jianyong Yang, Yonghui Huang, Wang Yao, Jiaping Li. Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response. Oncotarget 2015; 6(27): 24550 doi: 10.18632/oncotarget.4076
|
| 64 |
Kurtis Graham, Joshua I. Murphy, Gurtej K. Dhoot. SULF1/SULF2 reactivation during liver damage and tumour growth. Histochemistry and Cell Biology 2016; 146(1): 85 doi: 10.1007/s00418-016-1425-8
|
| 65 |
Meng-Meng Qu, Yuan-Hui Zhu, Yi-Xiang Li, Zhi-Fan Li, Jin-Kui Li, Yong-Sheng Xu, Manishkumar Shrestha, Jun-Qiang Lei. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Medicine 2021; 100(46): e27349 doi: 10.1097/MD.0000000000027349
|
| 66 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 67 |
Ramazan Dertli, Mehmet Asil, Murat Biyik, Ahmet Karakarcayildiz, Muharrem Keskin, Hakan Mevlüt Göktepe, Yusuf Kayar, Huseyin Ataseven. Can Hematological Inflammatory Parameters Predict Mortality in Hepatocellular Carcinoma?. Journal of Gastrointestinal Cancer 2021; 52(2): 666 doi: 10.1007/s12029-020-00448-2
|
| 68 |
Yixiong Lin, Jianjun Liu, Yuqi Huang, Dingli Liu, Guowei Zhang, Heping Kan. microRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7. Translational Oncology 2017; 10(2): 211 doi: 10.1016/j.tranon.2017.01.010
|
| 69 |
Erica A. Golemis, Paul Scheet, Tim N. Beck, Eward M. Scolnick, David J. Hunter, Ernest Hawk, Nancy Hopkins. Molecular mechanisms of the preventable causes of cancer in the United States. Genes & Development 2018; 32(13-14): 868 doi: 10.1101/gad.314849.118
|
| 70 |
Robert G. Gish, Bruce D. Given, Ching-Lung Lai, Stephen A. Locarnini, Johnson Y.N. Lau, David L. Lewis, Thomas Schluep. Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities. Antiviral Research 2015; 121: 47 doi: 10.1016/j.antiviral.2015.06.008
|
| 71 |
Sina Feustel, Fabiola Ayón-Pérez, Ana Sandoval-Rodriguez, Roberto Rodríguez-Echevarría, Homero Contreras-Salinas, Juan Armendáriz-Borunda, L. V. Sánchez-Orozco. Protective Effects of Moringa oleifera on HBV Genotypes C and H Transiently Transfected Huh7 Cells. Journal of Immunology Research 2017; 2017: 1 doi: 10.1155/2017/6063850
|
| 72 |
Marina A. Darenskaya, Lubov I. Kolesnikova, Sergey I. Kolesnikov. Free radical reactions in socially significant infectious diseases: HIV infection, hepatitis, tuberculosis. Annals of the Russian academy of medical sciences 2020; 75(3): 196 doi: 10.15690/vramn1328
|
| 73 |
Cyrille Lionel Kamga Bomgning, Pierre Valery Kemdoum Sinda, Beaudelaire Kemvoufo Ponou, Agathe Lambou Fotio, Mathias Kenfack Tsague, Borice Tapondjou Tsafack, Jonas Kühlborn, Elvine Pami Mbuyo-Nguelefack, Rémy Bertrand Teponno, Till Opatz, Léon Azefack Tapondjou, Télesphore Benoit Nguelefack. Hepatoprotective effects of extracts, fractions and compounds from the stem bark of Pentaclethra macrophylla Benth: Evidence from in vitro and in vivo studies. Biomedicine & Pharmacotherapy 2021; 136: 111242 doi: 10.1016/j.biopha.2021.111242
|
| 74 |
Wai Yeow Lee, Maulana Bachtiar, Cheryl C. S. Choo, Caroline G. Lee. Comprehensive review of Hepatitis B Virus‐associated hepatocellular carcinoma research through text mining and big data analytics. Biological Reviews 2019; 94(2): 353 doi: 10.1111/brv.12457
|
| 75 |
Iram Fatima, Sobia Kanwal, Tariq Mahmood. Natural Products Mediated Targeting of Virally Infected Cancer. Dose-Response 2019; 17(1): 155932581881322 doi: 10.1177/1559325818813227
|
| 76 |
Jun Fu, Qinjunjie Chen, Zisen Lai, Kongying Lin, Guoxu Fang, Zongren Ding, Yuzhen Gao, Yongyi Zeng. A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10668-x
|
| 77 |
Ibrahim Ahmed Shaikh, Uday M. Muddapur, Krithika C, Shrikanth Badiger, Madhura Kulkarni, Mater H. Mahnashi, Saleh A. Alshamrani, Mohammed A. Huneif, Sunil S. More, Aejaz Abdullatif Khan, S. M. Shakeel Iqubal. In Silico Molecular Docking and Simulation Studies of Protein HBx Involved in the Pathogenesis of Hepatitis B Virus-HBV. Molecules 2022; 27(5): 1513 doi: 10.3390/molecules27051513
|
| 78 |
Saranya Chidambaranathan-Reghupaty, Paul B. Fisher, Devanand Sarkar. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 1 doi: 10.1016/bs.acr.2020.10.001
|
| 79 |
Juan Du, Fuxiang Bai, Peiqing Zhao, Xiaoyan Li, Xueen Li, Lifen Gao, Chunhong Ma, Xiaohong Liang. Hepatitis B core protein promotes liver cancer metastasis through miR-382-5p/DLC-1 axis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2018; 1865(1): 1 doi: 10.1016/j.bbamcr.2017.09.020
|
| 80 |
Ryan S. Chiang, Ashton A. Connor, Brant A. Inman, Wen-Chi Foo, David N. Howell, John F. Madden, Matthew J. Ellis, Aparna S. Rege, Michael R. Harrison, Fumitaka Koga. Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor. Case Reports in Urology 2020; 2020: 1 doi: 10.1155/2020/8881841
|
| 81 |
Jia-fu Feng, Yu-wei Yang, Dong Wang, Jie Tang, Gang Xie, Ling-ying Fan. Relationship between oxidative stress in patients with HBV-induced liver disease and HBV genotype/drug-resistant mutation. Frontiers in Laboratory Medicine 2017; 1(4): 211 doi: 10.1016/j.flm.2017.12.005
|
| 82 |
Mara Klöhn, Jil Alexandra Schrader, Yannick Brüggemann, Daniel Todt, Eike Steinmann. Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma. Cancers 2021; 13(22): 5867 doi: 10.3390/cancers13225867
|
| 83 |
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 33 doi: 10.1016/B978-0-323-98806-3.00023-4
|
| 84 |
Deepika Divya Kadiri, Sujatha Peela, Debayan Ganguli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 51 doi: 10.1016/B978-0-323-98806-3.00002-7
|
| 85 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
| 86 |
Jing Zhou, Fada Wang, Lanqing Li, Enqiang Chen. Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA. Precision Clinical Medicine 2022; 5(4) doi: 10.1093/pcmedi/pbac030
|
| 87 |
Mehdi Fazlalipour, Zohreh-al-sadat Ghoreshi, Hamid Reza Molaei, Nasir Arefinia. The Role of DNA Viruses in Human Cancer. Cancer Informatics 2023; 22 doi: 10.1177/11769351231154186
|
| 88 |
Shuqin Zhang, Shan Gao, Man Zhao, Yunxia Liu, Yanan Bu, Qiulei Jiang, Qiang Zhao, Lihong Ye, Xiaodong Zhang. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein. Cancer Letters 2017; 392: 94 doi: 10.1016/j.canlet.2017.02.003
|
| 89 |
Amelie S. Troschel, Alexander Miks, Anna Hüsing‐Kabar, Hauke S. Heinzow, Hartmut H. Schmidt, Fabian M. Troschel, Iyad Kabar. Inflammation, etiologies and Model for End‐stage Liver Disease score: What makes liver disease patients susceptible to developing colorectal neoplasia?. Hepatology Research 2020; 50(3): 342 doi: 10.1111/hepr.13463
|
| 90 |
Caian L. Vinhaes, Luís A. B. Cruz, Rodrigo C. Menezes, Thomas A. Carmo, María B. Arriaga, Artur T. L. Queiroz, Manoel Barral-Netto, Bruno B. Andrade. Chronic Hepatitis B Infection Is Associated with Increased Molecular Degree of Inflammatory Perturbation in Peripheral Blood. Viruses 2020; 12(8): 864 doi: 10.3390/v12080864
|
| 91 |
Yaw-Sen Chen, Pei-Min Hsieh, Hung-Yu Lin, Chao-Ming Hung, Gin-Ho Lo, Yao-Chun Hsu, I.-Cheng Lu, Chih-Yuan Lee, Tsung-Chin Wu, Jen-Hao Yeh, Pojen Hsiao, Yu-Chan Li, Ya-Chin Wang, Kun-Chou Hsieh, Chih-Wen Lin. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01807-4
|
| 92 |
Heena B Choudhary, Satish K Mandlik, Deepa S Mandlik. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World Journal of Gastrointestinal Pathophysiology 2023; 14(3): 46-70 doi: 10.4291/wjgp.v14.i3.46
|
| 93 |
Lei Li, Hong-Hai Hong, Shi-Ping Chen, Cai-Qi Ma, Han-Yan Liu, Ya-Chao Yao. Activation of AMPK/MnSOD signaling mediates anti-apoptotic effect of hepatitis B virus in hepatoma cells. World Journal of Gastroenterology 2016; 22(17): 4345-4353 doi: 10.3748/wjg.v22.i17.4345
|
| 94 |
Chaojun Zhang, Chanchan Xiao, Guanhua Ren, Dongmei Cai, Long Long, Jilin Li, Kezhi Li, Yanping Tang, Tianren Huang, Wei Deng. C-terminal-truncated hepatitis B virus X protein promotes hepatocarcinogenesis by activating the MAPK pathway. Microbial Pathogenesis 2021; 159: 105136 doi: 10.1016/j.micpath.2021.105136
|
| 95 |
Guifang Yu, Xuezhu Chen, Shudi Chen, Weipeng Ye, Kailian Hou, Min Liang. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-0888-7
|
| 96 |
Sayed Sartaj Sohrab, Riya Raj, Amka Nagar, Susan Hawthorne, Ana Cláudia Paiva-Santos, Mohammad Amjad Kamal, Mai M. El-Daly, Esam I. Azhar, Ankur Sharma. Chronic Inflammation’s Transformation to Cancer: A Nanotherapeutic Paradigm. Molecules 2023; 28(11): 4413 doi: 10.3390/molecules28114413
|
| 97 |
Erika Hernández-Aquino, Pablo Muriel. Beneficial effects of naringenin in liver diseases: Molecular mechanisms. World Journal of Gastroenterology 2018; 24(16): 1679-1707 doi: 10.3748/wjg.v24.i16.1679
|
| 98 |
Zhuoran Wang, Nan Li, Peng Cai, Cunzhen Zhang, Guangwen Cao, Jianhua Yin. Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1249198
|
| 99 |
Jianguo Li, Yaqi Chen, Xuecong Guo, Xiaofei Bai, Xu Xu, Tong Han, Ailing Tan, Nana Liu, Yuchen Xia, Qiaoyi Sun, Xudong Guo, Jie Chen, Jiuhong Kang. lncNBAT1/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells. Molecular Therapy - Nucleic Acids 2022; 27: 1064 doi: 10.1016/j.omtn.2022.01.015
|
| 100 |
Mengmeng Deng, Junwei Hou, Jun Hu, Shuo Wang, Mi Chen, Lizhao Chen, Ying Ju, Changfei Li, Songdong Meng. Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma. Cancer Letters 2016; 383(1): 62 doi: 10.1016/j.canlet.2016.09.028
|
| 101 |
Zhaoyang Qian, Junbo Liang, Rong Huang, Wei Song, Jianming Ying, Xinyu Bi, Jianjun Zhao, Zhenyu Shi, Wenjie Liu, Jianmei Liu, Zhiyu Li, Jianguo Zhou, Zhen Huang, Yefan Zhang, Dongbing Zhao, Jianxiong Wu, Liming Wang, Xiao Chen, Rui Mao, Yanchi Zhou, Lei Guo, Hanjie Hu, Dazhuang Ge, Xingchen Li, Zhiwen Luo, Jinjie Yao, Tengyan Li, Qichen Chen, Bingzhi Wang, Zhewen Wei, Kun Chen, Chunfeng Qu, Jianqiang Cai, Yuchen Jiao, Li Bao, Hong Zhao. HBV integrations reshaping genomic structures promote hepatocellular carcinoma. Gut 2024; : gutjnl-2023-330414 doi: 10.1136/gutjnl-2023-330414
|
| 102 |
G.Y. Minuk, Y. Baruch. Hepatitis B viral infection of hepatic progenitor cells. Resolving unresolved questions?. Medical Hypotheses 2016; 91: 24 doi: 10.1016/j.mehy.2016.04.011
|
| 103 |
Sanjit Boora, Vikrant Sharma, Sulochana Kaushik, Ajoy Varma Bhupatiraju, Sandeep Singh, Samander Kaushik. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Brazilian Journal of Microbiology 2023; 54(2): 679 doi: 10.1007/s42770-023-00970-y
|
| 104 |
Christopher P. Corkum, Louisa L. Wiede, Cara L.-A. Ruble, Jiabin Qiu, Patricia M. Mulrooney-Cousins, Meredith A. Steeves, David E. Watson, Tomasz I. Michalak. Identification of antibodies cross-reactive with woodchuck immune cells and activation of virus-specific and global cytotoxic T cell responses by anti-PD-1 and anti-PD-L1 in experimental chronic hepatitis B and persistent occult hepadnaviral infection. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.1011070
|
| 105 |
Alexandra Sexton-Oates, Alexei Novoloaca, Akram Ghantous, Zdenko Herceg. Environmental Epigenetics in Toxicology and Public Health. 2020; : 171 doi: 10.1016/B978-0-12-819968-8.00007-X
|
| 106 |
Beatriz Vieira Neto, Valéria Tavares, Joana M. O. Santos, Fátima Cerqueira, Deolinda Pereira, Rui Medeiros. Map of thrombogenesis in viral infections and viral-driven tumours. Discover Oncology 2023; 14(1) doi: 10.1007/s12672-022-00610-1
|
| 107 |
Yueh-Te Lin, Long-Bin Jeng, Wen-Ling Chan, Ih-Jen Su, Chiao-Fang Teng. Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins: Clinical and Molecular Implications in Hepatocellular Carcinoma. Viruses 2021; 13(5): 862 doi: 10.3390/v13050862
|
| 108 |
Caitlin A. McIntyre, Joanne F. Chou, Mithat Gonen, Jinru Shia, Maya Gambarin-Gelwan, Vinod P. Balachandran, T. Peter Kingham, Peter J. Allen, Jeffrey A. Drebin, William R. Jarnagin, Michael I. D'Angelica. Hepatocellular carcinoma in patients with no identifiable risk factors. HPB 2021; 23(1): 118 doi: 10.1016/j.hpb.2020.05.005
|
| 109 |
Shanshan Chen, Hao Chen, Shanshan Gao, Shili Qiu, Hu Zhou, Mingxia Yu, Jiancheng Tu. Differential expression of plasma microRNA‐125b in hepatitis B virus‐related liver diseases and diagnostic potential for hepatitis B virus‐induced hepatocellular carcinoma. Hepatology Research 2017; 47(4): 312 doi: 10.1111/hepr.12739
|
| 110 |
Li Zhou, Ji Wen, Zhao Huang, Edouard C. Nice, Canhua Huang, Haiyuan Zhang, Qifu Li. Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis. PROTEOMICS – Clinical Applications 2017; 11(3-4) doi: 10.1002/prca.201600089
|
| 111 |
Yongkang Wang, Yinfeng Yang, Honglei Gao, Ting Ouyang, Luyao Zhang, Jili Hu, Sheng Hu, Hongxing Kan. Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.566183
|
| 112 |
Arash Letafati, Sajad Najafi, Mehran Mottahedi, Mohammad Karimzadeh, Ali Shahini, Setareh Garousi, Mohammad Abbasi-Kolli, Javid Sadri Nahand, Seyed Saeed Tamehri Zadeh, Michael R. Hamblin, Neda Rahimian, Mohammad Taghizadieh, Hamed Mirzaei. MicroRNA let-7 and viral infections: focus on mechanisms of action. Cellular & Molecular Biology Letters 2022; 27(1) doi: 10.1186/s11658-022-00317-9
|
| 113 |
Jinyu Zhang, Yi Zhang, Sushant Khanal, Dechao Cao, Juan Zhao, Xindi Dang, Lam Ngoc Thao Nguyen, Madison Schank, Xiao Y. Wu, Yong Jiang, Shunbin Ning, Ling Wang, Mohamed El Gazzar, Jonathan P. Moorman, Haitao Guo, Zhi Q. Yao. Synthetic gRNA/Cas9 ribonucleoprotein targeting HBV DNA inhibits viral replication. Journal of Medical Virology 2023; 95(7) doi: 10.1002/jmv.28952
|
| 114 |
Yue ZHAO, Jing-jing MAO, Rui-ping SHE, Feng-jiao HU, Majid H Soomro, Rui-ping LIANG, Yi-fei YANG, Fang DU, Tong-tong WANG, Zhao-jie GUO, Min-heng CHENG. Hepatitis associated with hepatitis B virus in broilers. Journal of Integrative Agriculture 2016; 15(1): 191 doi: 10.1016/S2095-3119(14)60914-X
|
| 115 |
Michael Karin. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance. Precision Clinical Medicine 2018; 1(1): 21 doi: 10.1093/pcmedi/pby005
|
| 116 |
Soumendu Mahapatra, Smrutishree Mohanty, Rasmita Mishra, Punit Prasad. Human Microbiome in Health and Disease - Part A. Progress in Molecular Biology and Translational Science 2022; 191: 83 doi: 10.1016/bs.pmbts.2022.07.007
|
| 117 |
Hao Li, Chunyu Sheng, Shan Wang, Lang Yang, Yuan Liang, Yong Huang, Hongbo Liu, Peng Li, Chaojie Yang, Xiaoxia Yang, Leili Jia, Jing Xie, Ligui Wang, Rongzhang Hao, Xinying Du, Dongping Xu, Jianjun Zhou, Mingzhen Li, Yansong Sun, Yigang Tong, Qiao Li, Shaofu Qiu, Hongbin Song. Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9. Frontiers in Cellular and Infection Microbiology 2017; 7 doi: 10.3389/fcimb.2017.00091
|
| 118 |
Junting Cao, Zhiguo Wen, Yunsheng Zhang, Bo Zhang, Ying Chen, Guangnan Xing, Yongbao Wu, Zhengkui Zhou, Xiaolin Liu, Shuisheng Hou. Effects of DHAV-3 infection on innate immunity, antioxidant capacity, and lipid metabolism in ducks with different DHAV-3 susceptibilities. Poultry Science 2024; 103(3): 103374 doi: 10.1016/j.psj.2023.103374
|
| 119 |
Patricia Villain, Paula Gonzalez, Maribel Almonte, Silvia Franceschi, Joakim Dillner, Ahti Anttila, Jin Young Park, Hugo De Vuyst, Rolando Herrero. European Code against Cancer 4th Edition: Infections and Cancer. Cancer Epidemiology 2015; 39: S120 doi: 10.1016/j.canep.2015.10.006
|
| 120 |
E. Okeke, P. Mark Davwar, B. Mullen, M. Duguru, O. Agbaji, A. Sagay, R. Murphy, C. Hawkins. The impact of HIV on hepatocellular cancer survival in Nigeria. Tropical Medicine & International Health 2021; 26(3): 335 doi: 10.1111/tmi.13532
|
| 121 |
Chiao-Fang Teng, Chun-Hui Yu, Hong-Yi Chang, Wen-Chuan Hsieh, Tzu-Hua Wu, Jia-Hui Lin, Han-Chieh Wu, Long-Bin Jeng, Ih-Jen Su. Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46891-5
|
| 122 |
Zhiliang He, Youjia Yu, Yunhong Nong, Lingyao Du, Cong Liu, Yong Cao, Lang Bai, Hong Tang. Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein. Oncology Letters 2017; 14(2): 1323 doi: 10.3892/ol.2017.6296
|
| 123 |
Shaozhen Rui, Jun Yan, Hui Zhang, Zhengfeng Wang, Wence Zhou. Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy. Medicine 2017; 96(30): e7608 doi: 10.1097/MD.0000000000007608
|
| 124 |
Maria Bousali, Timokratis Karamitros. Hepatitis B Virus Integration into Transcriptionally Active Loci and HBV-Associated Hepatocellular Carcinoma. Microorganisms 2022; 10(2): 253 doi: 10.3390/microorganisms10020253
|
| 125 |
Vishal S. Patil, Darasaguppe R. Harish, Umashankar Vetrivel, Sanjay H. Deshpande, Pukar Khanal, Harsha V. Hegde, Subarna Roy, Sunil S. Jalalpure. Pharmacoinformatics Analysis Reveals Flavonoids and Diterpenoids from Andrographis paniculata and Thespesia populnea to Target Hepatocellular Carcinoma Induced by Hepatitis B Virus. Applied Sciences 2022; 12(21): 10691 doi: 10.3390/app122110691
|
| 126 |
Ming Wang, Dong Xi, Qin Ning. Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatology International 2017; 11(2): 171 doi: 10.1007/s12072-016-9779-5
|
| 127 |
Lacey R. Lopez, Rachel M. Bleich, Janelle C. Arthur. Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression. Annual Review of Medicine 2021; 72(1): 243 doi: 10.1146/annurev-med-080719-091604
|
| 128 |
Tiziana Vescovo, Benedetta Pagni, Mauro Piacentini, Gian Maria Fimia, Manuela Antonioli. Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00047
|
| 129 |
Wen-Tao Wang, Hua Ye, Pan-Pan Wei, Bo-Wei Han, Bo He, Zhen- Hua Chen, Yue-Qin Chen. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner. Journal of Hematology & Oncology 2016; 9(1) doi: 10.1186/s13045-016-0348-0
|
| 130 |
S. N. Batskikh. Resolved Hepatitis B: Achieved or Imaginary Wellbeing?. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(1): 7 doi: 10.22416/1382-4376-2021-31-1-7-19
|
| 131 |
Meng Xue, Xiaona Lin, Qiu‐Xiong Lin, Xiaoyong Pu, Jiumin Liu, Xing‐Fang Li, Jun Hou, Xudong Liu, Ren Chen. Association between hepatitis B and E virus infection and hepatocellular carcinoma risk. International Journal of Cancer 2021; 148(12): 2974 doi: 10.1002/ijc.33505
|
| 132 |
Dehai Wu, Hao Liang, Hao Wang, Changhu Duan, Hamza Yazdani, Jinan Zhou, Yujia Pan, Baga Shan, Zhilei Su, Jinping Wei, Tiangang Cui, Sheng Tai. Hepatitis B virus‑X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9178
|
| 133 |
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 83 doi: 10.1016/B978-0-323-98807-0.00003-X
|
| 134 |
Mariantonietta Di Stefano, Giuseppina Faleo, Thomas Leitner, Wei Zheng, Yang Zhang, Amna Hassan, Marwan J. Alwazzeh, Josè R. Fiore, Mona Ismail, Teresa A. Santantonio. Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals. Viruses 2023; 15(2): 458 doi: 10.3390/v15020458
|
| 135 |
Hyo Jeong Kang, Dal-Hee Chung, Chang Ohk Sung, Su Hyun Yoo, Eunsil Yu, Nayoung Kim, Sy-Hye Lee, Ji-Young Song, Chong Jai Kim, Jene Choi. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development. Oncotarget 2017; 8(16): 27263 doi: 10.18632/oncotarget.15930
|
| 136 |
Elham Shirvani-Dastgerdi, Robert E Schwartz, Alexander Ploss. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Current Opinion in Virology 2016; 20: 1 doi: 10.1016/j.coviro.2016.07.009
|
| 137 |
Ying Zhang, Wei Guo, Zhumei Zhan, Ou Bai. Carcinogenic mechanisms of virus-associated lymphoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1361009
|
| 138 |
Zuojian Hu, Huaping Chen, Siyuan Chen, Zhili Huang, Shanzi Qin, Jianing Zhong, Xue Qin, Shan Li. The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma. Medicine 2019; 98(9): e14749 doi: 10.1097/MD.0000000000014749
|
| 139 |
Xuesong Deng, Jun Cheng, Naiyang Zhan, Jianwei Chen, Yongqiang Zhan, Yong Ni, Caixian Liao. MicroRNA‑135a expression is upregulated in hepatocellular carcinoma and targets long non‑coding RNA TONSL‑AS1 to suppress cell proliferation. Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13069
|
| 140 |
R. N. Mustafin. The hypothesis of the origin of viruses from transposons. Molecular Genetics Microbiology and Virology (Russian version) 2018; 36(4): 182 doi: 10.17116/molgen201836041182
|